NINDS Director Walter J. Koroshetz, MD recently shared a new Director's Message. In the message, he describes NINDS participation in the Accelerating Leading-edge Science in ALS (ALS2) initiative, a partnership between the NIH Common Fund and four NIH Institutes: the National Institute on Aging (NIA), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of General Medical Sciences (NIGMS), and NINDS.
The answers to ALS will take time to uncover, but through the ALS2 initiative, NINDS hopes to dramatically advance our understanding of what triggers ALS and what drives its rapid progression. Elucidating these underlying mechanisms will be a critical step toward testing potentially more effective therapeutics that are so needed to treat this tragic disease.